Connect your AI

LivaNova LIVN Investing Cash Flow

Investing Cash Flow at other companies

AbbottABT

-$20.32B-4,224%

HaemoneticsHAE

-$86.61M—

MedtronicMDT

-$917M-87.1%

ITG

Integer HoldingsITGR

-$37.9M+80.8%

ResMedRMD

-$58.03M-82.6%

Boston ScientificBSX

-$591M-18.2%

Other financials

Income statement

Revenue$362.3M+14.3%

Gross profit$243.7M+12.7%

Operating income$41.5M-14.7%

Net income$22.3M+107%

EPS (diluted)$0.40+107%

Balance sheet

Cash & equivalents$539.7M-26.9%

Total debt$340.9M-49.7%

Total equity$1.2B+17.1%

Total assets$2.5B-1.7%

Cash flow

Operating cash flow$15.2M-36.5%

CapEx$14.3M+32.4%

Free cash flow$926.0K-93.0%

Valuation

Market cap$4.32B+62.8%

Profitability

Gross margin67.5%-0.5pp

Operating margin13.4%+0.8pp

Net margin-16.1%-18.0pp

FCF margin11.2%-0.2pp

Returns & leverage

Return on equity-17.6%-19.5pp

Debt / equity0.3×-0.4×

Current ratio1.3×-0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is LivaNova's investing cash flow?: LivaNova (LIVN) reported investing cash flow of -$14.58M in Q1 2026.
How has LivaNova's investing cash flow changed year-over-year?: LivaNova's investing cash flow decreased by 37.2% year-over-year, from -$10.63M to -$14.58M.
What is the long-term trend for LivaNova's investing cash flow?: Over 3 years (2022 to 2025), LivaNova's investing cash flow has grown at a 23.8% compound annual growth rate (CAGR), from -$38.41M to -$72.91M.
What does investing cash flow mean?: Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.